Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Prestige sells three shampoo brands

This article was originally published in The Tan Sheet

Executive Summary

Prestige Brands Holdings sells three shampoo brands - Prell, Denorex Dandruff Shampoo andZincon Dandruff Shampoo - to Ultimark Products, the Irvington, N.Y.-based firm says Oct. 29. The brands, which make up 2 percent to 3 percent of the firm's annual sales, sold for $8 million with an additional payment of $1 million due Oct. 28, 2010. Prestige said it will use the proceeds to pay down its debt. "The successful sale of these businesses allows us to increase focus on our two larger segments, over-the-counter healthcare and household cleaning products, to enhance shareholder value," said President and CEO Matthew Mannelly. Prestige also notes board members Peter Mann and Vincent Hemmer resigned. Mann, the firm's founder and a former CEO and chairman, will pursue a new business opportunity, and Hemmer, a private equity owner of Prestige stock, resigned after his firm, GTCR Golder Rauner, significantly reduced its holdings, the firm said Oct. 27

You may also be interested in...

Startup Blacksmith Debuts With Luden's, PediaCare Acquisition From McNeil

Blacksmith Brands, led by industry veteran Peter Mann, launches with the acquisition of five OTC brands from Johnson & Johnson/McNeil Consumer, including Luden's throat lozenges and PediaCare children's cough/cold remedies

Prenatal Vitamin D Benefit In Preventing Childhood Asthma Fades By Age 6

University of Rochester researchers say a benefit of daily prenatal vitamin D in preventing asthma in children up to 3 found in their 2016 study doesn't extend until age 6. They encourage more research, including analyzing whether supplementation should continue in young children.

UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System

At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts